Secretary of Defense Esper Calls on Private Sector to Join Forces with DoD in the Development of AI
Client Alert | 1 min read | 11.21.19
On November 5, 2019, Secretary of Defense Mark Esper delivered remarks on the importance of Artificial Intelligence (AI) at the National Security Commission on Artificial Intelligence Public Conference. In his remarks, Secretary Esper identified AI as a “core, critical” emerging technology for the Department of Defense (DoD), where the goal is “to get the war fighter into the cloud,” and help deliver battlefield data to troops more quickly and predict necessary equipment maintenance from afar, among other things. He also called on the private sector to work with DoD “to lead the world in responsible AI research and application,” emphasizing the need to develop principles for using AI in a lawful and ethical manner, consistent with the U.S.’s AI Strategy Plan, as we reported on here, and in a statement foreshadowing anticipated export controls on certain areas of AI, likely to be issued by the Department of the Commerce in proposed form by the end of the year, Secretary Esper admonished, “ [o]ur collective security must not be diminished by a short and narrow sighted focus on economic opportunity.”
Insights
Client Alert | 4 min read | 08.29.25
Gender-Affirming Care Targeted for Potential False Claims Act Enforcement
On August 19, 2025, the Office of Personnel Management (OPM) informed insurers participating in the Federal Employees Health Benefits or Postal Service Health Benefits programs that gender-affirming care would no longer be covered for federal workers starting in 2026. This coverage decision is the Trump Administration’s latest action stemming from Executive Order 14187 which aims to prevent certain treatments, such as gender-affirming hormone therapy, surgeries, and puberty blockers for those under the age of 19. As previously discussed, the Administration has also signaled its intent to use various law enforcement tools against gender-affirming care, including Section 5 of the Federal Trade Commission Act to police false or unsupported claims by medical professionals about gender-affirming treatments.
Client Alert | 4 min read | 08.28.25
9th Circuit Marches Forward to the Future Finding Digital Assets Are Protected Under Trademark Law
Client Alert | 2 min read | 08.27.25
CPSC Maintains Momentum on eFiling Requirements for Consumer Products
Client Alert | 10 min read | 08.27.25
The New EU “Pharma Package”: Advertising – A Comparison of Commission/Parliament/Council Positions